APGE · Insider trading · 13F holders · Congress trades
Apogee Therapeutics, Inc. (APGE)
Who is buying and selling APGE: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 51
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $738K
- Congress trades, 12 months
- 0
APGE at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 1 APGE insider filed 1 sale worth $738K on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
- 51 13F filers hold APGE among their 50 largest positions, worth $4.1B combined, including Joseph Edelman, George Soros, Alec Litowitz and Dmitry Balyasny. The biggest bets by portfolio weight are Venrock Adviser, LLC (34.2%), Slotnik Capital, LLC (9.6%) and Twin Securities, Inc. (8.1%). In their latest 13Fs, 6 managers opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in APGE.
APGE insider trading
Between Aug 1, 2026 and Oct 29, 2026, 1 APGE insider filed 1 sale worth $738K on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Dambkowski Carl | Chief Medical Officer | Sale10b5-1 | 5,500 | $134.17 | $738K | SEC |
Who owns APGE? Hedge funds and superinvestors
51 13F filers hold APGE among their 50 largest positions, worth $4.1B combined, including Joseph Edelman, George Soros, Alec Litowitz and Dmitry Balyasny. The biggest bets by portfolio weight are Venrock Adviser, LLC (34.2%), Slotnik Capital, LLC (9.6%) and Twin Securities, Inc. (8.1%). In their latest 13Fs, 6 managers opened a new position and 2 added to one.
Superinvestors holding APGE: Joseph Edelman 2.7% · George Soros 1.2% · Alec Litowitz 0.5% · Dmitry Balyasny 0.4%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Venrock Adviser, LLCHedge fund | 34.2% | $1.1B | 8,493,321 | +0.0% shares | Q2 2026 |
| Hbk Investments L PHedge fund | 4.8% | $378.3M | 2,850,000 | — | Q2 2026 |
| Driehaus Capital Management LLCHedge fund | 1.3% | $231.0M | 1,740,101 | -9.4% shares | Q2 2026 |
| Dmitry BalyasnyHedge fund | 0.4% | $221.0M | 1,665,102 | — | Q2 2026 |
| Glazer Capital, LLCHedge fund | 5.5% | $217.8M | 1,641,042 | — | Q2 2026 |
| Paradigm Biocapital Advisors LPHedge fund | 3.9% | $209.2M | 1,576,385 | +16.9% shares | Q2 2026 |
| Pentwater Capital Management LPHedge fund | 1.5% | $189.1M | 1,425,000 | — | Q2 2026 |
| Joseph EdelmanHedge fund | 2.7% | $173.6M | 1,308,113 | -15.1% shares | Q2 2026 |
| Affinity Asset Advisors, LLCHedge fund | 6.5% | $131.0M | 987,000 | -23.2% shares | Q2 2026 |
| First Light Asset Management, LLCHedge fund | 7.5% | $123.5M | 930,289 | +61.3% shares | Q2 2026 |
| Kryger Capital LLCHedge fund | 5.6% | $98.6M | 742,555 | — | Q2 2026 |
| First Trust Capital Management L.P.Mutual fund manager | 4.8% | $83.0M | 625,182 | — | Q2 2026 |
| Remedium Capital Partners, LLCInstitutional asset manager | 17.2% | $77.9M | 586,691 | +0.5% shares | Q2 2026 |
| George SorosAsset manager | 1.2% | $74.9M | 564,500 | — | Q2 2026 |
| Whitebox Advisors LLCHedge fund | 2.9% | $59.7M | 450,001 | — | Q2 2026 |
| AQR Arbitrage LLCHedge fund | 1.0% | $57.1M | 429,900 | — | Q2 2026 |
| Alec LitowitzHedge fund | 0.5% | $53.0M | 399,123 | — | Q2 2026 |
| Opaleye Management Inc.Hedge fund | 4.7% | $51.8M | 390,000 | +0.0% shares | Q2 2026 |
| TIG Advisors, LLCHedge fund | 2.2% | $48.3M | 364,250 | — | Q2 2026 |
| Cinctive Capital Management LPHedge fund | 1.9% | $46.5M | 350,165 | — | Q2 2026 |
| Polar Asset Management Partners Inc.Hedge fund | 1.0% | $42.8M | 322,467 | — | Q2 2026 |
| Nexpoint Asset Management, L.P.Mutual fund manager | 2.7% | $39.8M | 299,940 | — | Q2 2026 |
| Fairmount Funds Management LLCHedge fund | 2.6% | $39.6M | 298,647 | +0.0% shares | Q2 2026 |
| Slotnik Capital, LLCHedge fund | 9.6% | $34.6M | 260,740 | New | Q2 2026 |
| Absolute Gestao de Investimentos Ltda.Investment manager | 7.5% | $27.2M | 205,000 | — | Q2 2026 |
| Highbridge Capital Management LLCHedge fund | 1.1% | $20.7M | 155,857 | — | Q2 2026 |
| Sagefield Capital LPHedge fund | 1.5% | $20.6M | 155,135 | — | Q2 2026 |
| First Turn Management, LLCInstitutional asset manager | 2.0% | $18.4M | 138,822 | -73.0% shares | Q2 2026 |
| Twin Securities, Inc.Hedge fund | 8.1% | $15.9M | 120,000 | New | Q2 2026 |
| Melqart Asset Management (UK) LtdHedge fund | 1.5% | $15.6M | 117,249 | New | Q2 2026 |
The 30 largest of 51 positions, by value. Each manager counts with its latest 13F (Q2 2026: 51). Screen APGE in the grand portfolio →
APGE stock trades by members of Congress
No member of Congress has disclosed a trade in APGE.
APGE questions and answers
Are insiders buying APGE stock?
Between Aug 1, 2026 and Oct 29, 2026, 1 APGE insider filed 1 sale worth $738K on SEC Form 4, and no open-market purchases; 1 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own APGE?
51 13F filers hold APGE among their 50 largest positions, worth $4.1B combined, including Joseph Edelman, George Soros, Alec Litowitz and Dmitry Balyasny. The biggest bets by portfolio weight are Venrock Adviser, LLC (34.2%), Slotnik Capital, LLC (9.6%) and Twin Securities, Inc. (8.1%). In their latest 13Fs, 6 managers opened a new position and 2 added to one.
Has Congress traded APGE?
No member of Congress has disclosed a trade in APGE.
Who is the largest holder of APGE?
Among 13F filers, Venrock Adviser, LLC reports the largest APGE position, $1.1B (8,493,321 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Venrock Adviser, LLC's: 34.2% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.